Evidence map›Paper›PMID 19557000›Full record

ArticleEMBO reports2009

Ataxia telangiectasia mutated activation by transcription- and topoisomerase I-induced DNA double-strand breaks.

Olivier Sordet, Christophe E Redon, Josée Guirouilh-Barbat, Susan Smith, Stéphanie Solier, Céline Douarre, Chiara Conti, Asako J Nakamura, Benu B Das, Estelle Nicolas and 3 more

Open access · hybridAbstract read
In one paragraph

Article in EMBO reports, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 141 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
141citing papers in PubMed, 1 pooled it
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

141 citing papers in PubMed, 1 synthesis or guideline pooled it, 229 citations in OpenAlex.

  1. Relationships of FOXE1 and ATM genetic polymorphisms with papillary thyroid carcinoma risk: a meta-analysis.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2014
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. p53 activates circASCC3 to repress R-loops and enhance resistance to chemotherapy.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

81 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Olivier SordetLaboratory of Molecular Pharmacology, National Cancer Institute, NIH, Bethesda, MD 20892-4255, USA.
Christophe E Redon
Josée Guirouilh-Barbat
Susan Smith
Stéphanie Solier
Céline Douarre
Chiara Conti
Asako J Nakamura
Benu B Das
Estelle Nicolas
Kurt W Kohn
William M Bonner
Yves Pommier
National Cancer Institute · USLaboratoire de Biologie Cellulaire et Moléculaire du Contrôle de la Prolifération · FRNational Institute of Neurological Disorders and Stroke · US

Funding

DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer DrugsZIABC006150 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI POMMIER, YVES · 2009 to 2025
$23.0M
DNA Topoisomerases as Target of Action of Anticancer DrugsZIABC006161 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI POMMIER, YVES · 2009 to 2025
$16.8M
Studies of Histone Functions in Chromatin; H2AX and DNA DSBsZIABC006140 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI BONNER, WILLIAM · 2009 to 2015
$7.8M
Intramural NIH HHS
6 · The paper itself

Abstract

Ataxia telangiectasia mutated (ATM), the deficiency of which causes a severe neurodegenerative disease, is a crucial mediator for the DNA damage response (DDR). As neurons have high rates of transcription that require topoisomerase I (TOP1), we investigated whether TOP1 cleavage complexes (TOP1cc)-which are potent transcription-blocking lesions-also produce transcription-dependent DNA double-strand breaks (DSBs) with ATM activation. We show the induction of DSBs and DDR activation in post-mitotic primary neurons and lymphocytes treated with camptothecin, with the induction of nuclear DDR foci containing activated ATM, gamma-H2AX (phosphorylated histone H2AX), activated CHK2 (checkpoint kinase 2), MDC1 (mediator of DNA damage checkpoint 1) and 53BP1 (p53 binding protein 1). The DSB-ATM-DDR pathway was suppressed by inhibiting transcription and gamma-H2AX signals were reduced by RNase H1 transfection, which removes transcription-mediated R-loops. Thus, we propose that Top1cc produce transcription arrests with R-loop formation and generate DSBs that activate ATM in post-mitotic cells.

Indexed as

DNA Breaks, Double-StrandedAdaptor Proteins, Signal TransducingAlpha-AmanitinAnimalsAtaxia Telangiectasia Mutated ProteinsCamptothecinCell Cycle ProteinsCells, CulturedDichlororibofuranosylbenzimidazoleDNA-Binding ProteinsDNA Topoisomerases, Type IEnzyme InhibitorsFlow CytometryHistonesHumansIntracellular Signaling Peptides and ProteinsAdaptor Proteins, Signal TransducingAlpha-AmanitinAtaxia Telangiectasia Mutated ProteinsATM protein, humanCamptothecinCell Cycle ProteinsDichlororibofuranosylbenzimidazoleDNA-Binding ProteinsDNA Topoisomerases, Type IEnzyme InhibitorsH2AX protein, humanHistonesIntracellular Signaling Peptides and ProteinsMDC1 protein, humanNuclear ProteinsNucleic Acid Synthesis InhibitorsProtein Serine-Threonine KinasesRibonuclease Hribonuclease HITP53BP1 protein, humanTrans-ActivatorsTumor Suppressor p53-Binding Protein 1Tumor Suppressor Proteins

Identifiers

PMID19557000
PMCPMC2726680
OpenAlexW2148229099

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.